FDA Compliance Program Chapter 41 - Therapeutic Products Inspection of Tissue Establishments 7341.002A

Titel:
FDA Compliance Program Chapter 41 - Therapeutic Products Inspection of Tissue Establishments 7341.002A
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ComplianceActivities/Enforcement/CompliancePrograms/UCM238872.pdf

Dokumentenart:
Guidance Manual
Inhalt:
Compliance Program CBER Biologics

Zurück

GMP Seminare nach Thema